Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-05

FDA Approved: REGONOL — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for REGONOL (pyridostigmine bromide) filed by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REGONOL (Pyridostigmine bromide)

Snippet

SUPPL AP for REGONOL (PYRIDOSTIGMINE BROMIDE)